We are live on ! Find out more
TCRT icon

Alaunos Therapeutics

122 hedge funds and large institutions have $356M invested in Alaunos Therapeutics in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 31

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

0% more funds holding

Funds holding: 122122 (0)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.01% less ownership

Funds ownership: 0.28%0.27% (-0.01%)

5% less capital invested

Capital invested by funds: $376M → $356M (-$19.8M)

47% less call options, than puts

Call options by funds: $4.96M | Put options by funds: $9.29M

Holders
122
Holders Change
Holders Change %
0%
% of All Funds
3.04%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
12
Increased
34
Reduced
31
Closed
11
Calls
$4.96M
Puts
$9.29M
Net Calls
-$4.33M
Net Calls Change
-$255K
Name Holding Trade Value Shares
Change
Change in
Stake
TS
1
Third Security
Virginia
$59.6M
BlackRock
2
BlackRock
New York
$50.5M +$2.71M +3,048 +6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$50.3M +$1.91M +2,151 +4%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$31.7M -$16.2M -18,217 -35%
MVP
5
Miller Value Partners
Florida
$29.8M -$403K -454 -1%
State Street
6
State Street
Massachusetts
$27.2M -$709K -798 -3%
MP
7
MSD Partners
New York
$20.9M
Northern Trust
8
Northern Trust
Illinois
$9.96M -$53.3K -60 -0.6%
Morgan Stanley
9
Morgan Stanley
New York
$8.27M -$473K -533 -6%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$6.99M +$154K +173 +2%
Norges Bank
11
Norges Bank
Norway
$5.03M
UBS Group
12
UBS Group
Switzerland
$4.21M +$149K +168 +4%
Charles Schwab
13
Charles Schwab
California
$3.8M +$227K +256 +7%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$3.8M +$40.9K +46 +1%
TCIM
15
TIAA CREF Investment Management
New York
$2.12M -$28.4K -32 -1%
Group One Trading
16
Group One Trading
Illinois
$2.02M +$841K +947 +76%
CB
17
Commerce Bank
Missouri
$1.87M
TA
18
Teachers Advisors
New York
$1.49M +$45.3K +51 +3%
Janney Montgomery Scott
19
Janney Montgomery Scott
Pennsylvania
$1.39M -$71.1K -80 -5%
Swiss National Bank
20
Swiss National Bank
Switzerland
$1.34M
Wells Fargo
21
Wells Fargo
California
$1.34M +$59.5K +67 +5%
Brown Advisory
22
Brown Advisory
Maryland
$1.33M
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$1.31M
VIA
24
Vident Investment Advisory
Georgia
$1.3M +$38.2K +43 +3%
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$1.28M -$140K -158 -10%

TCRT Hedge Fund Activity: Q3 2017 in Review

122 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q3 2017, worth a combined $356M — down 5.3% from $376M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new TCRT positions and 11 closed out — a net gain of 1 holder — while 34 added to existing stakes and 31 trimmed.

The largest buyer was BlackRock, adding an estimated $2.71M. The largest seller was Susquehanna International Group, cutting an estimated $16.2M.

  • 122 institutional investors held Alaunos Therapeutics (TCRT) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $356M of Alaunos Therapeutics stock for Q3 2017, down 5.3% quarter-over-quarter.
  • 12 funds opened new Alaunos Therapeutics positions in Q3 2017 and 11 closed out, a net change of +1 holder.
  • The largest Alaunos Therapeutics buyer in Q3 2017 was BlackRock, an estimated $2.71M added.
  • The largest Alaunos Therapeutics seller in Q3 2017 was Susquehanna International Group, an estimated $16.2M sold.

Based on aggregated 13F filings for Q3 2017.